These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6483031)

  • 1. [Timely treatment of cerebrotendinous xanthomatosis, a hereditary disorder of cholesterol metabolism].
    Waterreus RJ; de Jager AE; Koopman BJ; Wolthers BG; Suurmeyer AJ
    Ned Tijdschr Geneeskd; 1984 Aug; 128(34):1604-7. PubMed ID: 6483031
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical abnormalities in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Berginer V
    Dev Neurosci; 1991; 13(4-5):363-70. PubMed ID: 1817043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrotendinous xanthomatosis: biochemical response to inhibition of cholesterol synthesis.
    Lewis B; Mitchell WD; Marenah CB; Cortese C; Reynolds EH; Shakir R
    Br Med J (Clin Res Ed); 1983 Jul; 287(6384):21-2. PubMed ID: 6407679
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cerebrotendinous xanthomatosis: long-term treatment with chenodesoxycholic acid (author's transl)].
    Wolf LM; Houdent C; Laudat MH; Brasseur G; Balacheff O; Uzac L
    Nouv Presse Med; 1982 Mar; 11(11):855-7. PubMed ID: 7070978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrotendinous xanthomatosis.
    Barron JL
    N Engl J Med; 1985 Aug; 313(7):455. PubMed ID: 4022076
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebrotendinous xanthomatosis.
    Grundy SM
    N Engl J Med; 1984 Dec; 311(26):1694-5. PubMed ID: 6504107
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Berginer VM; Salen G; Shefer S
    N Engl J Med; 1984 Dec; 311(26):1649-52. PubMed ID: 6504105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma esterification of cholestanol, normally and in cerebrotendinous xanthomatosis.
    Skrede S; Stokke KT
    Scand J Clin Lab Invest; 1974 Apr; 33(2):97-100. PubMed ID: 4853665
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebrotendinous xanthomatosis as a multisystem disease mimicking premature ageing.
    Dotti MT; Salen G; Federico A
    Dev Neurosci; 1991; 13(4-5):371-6. PubMed ID: 1817044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrotendinous xanthomatosis in Hawaii--a therapeutic failure.
    Hinman RC
    Hawaii Med J; 1984 Dec; 43(12):472-3, 477-8. PubMed ID: 6519979
    [No Abstract]   [Full Text] [Related]  

  • 11. Chenodeoxycholic acid normalizes elevated lipoprotein secretion and catabolism in cerebrotendinous xanthomatosis.
    Tint GS; Ginsberg H; Salen G; Le NA; Shefer S
    J Lipid Res; 1989 May; 30(5):633-40. PubMed ID: 2760539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cerebrotendinous xanthomatosis. A case report].
    Sabadini L; Gonnelli L; Anichini C; Funtò I; Marcolongo R; Dotti MG; Federico A
    Recenti Prog Med; 1996 Mar; 87(3):110-3. PubMed ID: 8650430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid.
    Pedley TA; Emerson RG; Warner CL; Rowland LP; Salen G
    Ann Neurol; 1985 Oct; 18(4):517-8. PubMed ID: 4073846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebrotendinous xanthomatosis and phytosterolemia].
    Nakamura T; Matsuzawa Y
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):794-7. PubMed ID: 3152095
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inborn errors of lipid metabolism. Effect of clofibrate on the level of blood lipids of patients with familial hyperlipoproteinemia (type 2, 3 and 4)].
    Sobra J; Heyrovský A; Sulc M; Horáková D
    Cas Lek Cesk; 1969 Aug; 108(36):1065-9. PubMed ID: 5807234
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebrotendinous xanthomatosis with cholestanolaemia--involvement of five individuals in a Malay family.
    Othman NH; Rahman SA
    Med J Malaysia; 1990 Dec; 45(4):275-80. PubMed ID: 2152046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of cerebrotendinous xanthomatosis with convulsive seizures].
    Matsumuro K; Takahashi K; Matsumoto H; Okatsu Y; Kuriyama M
    Rinsho Shinkeigaku; 1990 Feb; 30(2):207-9. PubMed ID: 2190743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein metabolism in cerebrotendinous xanthomatosis.
    Ballantyne CM; Vega GL; East C; Richards G; Grundy SM
    Metabolism; 1987 Mar; 36(3):270-6. PubMed ID: 3821507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case of cerebrotendinous xanthomatosis. I: Unusual ophthalmic features.
    Morgan SJ; McKenna P; Bosanquet RC
    Br J Ophthalmol; 1989 Dec; 73(12):1011-4. PubMed ID: 2611184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.